Advertisement
Screener

KALA BIO, INC. (KALA) Increase (Decrease) in Accounts Payable

2.8 / 5 stars · 68/120 Roast Me

KALA BIO, INC. Increase (Decrease) in Accounts Payable

KALA BIO, INC. (KALA) reported Increase (Decrease) in Accounts Payable of $156.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-19

  • KALA BIO, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $98.00K.
  • KALA BIO, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $58.00K, a 80.86% decline year-over-year.
  • KALA BIO, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $69.00K.
  • KALA BIO, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $259.00K, a 463.04% increase year-over-year.
  • KALA BIO, INC. increase (decrease) in accounts payable for fiscal 2025 was $358.00K.
  • KALA BIO, INC. increase (decrease) in accounts payable for fiscal 2024 was -$291.00K.
  • KALA BIO, INC. increase (decrease) in accounts payable for fiscal 2023 was -$1.90M.
  • KALA BIO, INC. increase (decrease) in accounts payable for fiscal 2022 was -$2.08M, a 164.25% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Payable 3 monthIncrease (Decrease) in Accounts Payable 6 monthIncrease (Decrease) in Accounts Payable 9 monthIncrease (Decrease) in Accounts Payable 12 month
2026-06-30$98.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19
$156.00K
10-Q · filed 2026-08-19
$225.00K
derived: sum of 3 quarters · filed 2026-08-19
$484.00K
derived: sum of 4 quarters · filed 2026-08-19
2026-03-31$58.00K
10-Q · filed 2026-05-15
$127.00K
derived: sum of 2 quarters · filed 2026-05-15
$386.00K
derived: sum of 3 quarters · filed 2026-05-15
$113.00K
derived: sum of 4 quarters · filed 2026-08-19
2025-12-31$69.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15
$328.00K
derived: sum of 2 quarters · filed 2026-04-15
$55.00K
derived: sum of 3 quarters · filed 2026-08-19
$358.00K
10-K · filed 2026-04-15
2025-09-30$259.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19
-$14.00K
derived: sum of 2 quarters · filed 2026-08-19
$289.00K
10-Q · filed 2025-11-19
$206.00K
derived: sum of 4 quarters · filed 2026-08-19
2025-06-30-$273.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19
$30.00K
10-Q · filed 2026-08-19
-$53.00K
derived: sum of 3 quarters · filed 2026-08-19
-$7.00K
derived: sum of 4 quarters · filed 2026-08-19
2025-03-31$303.00K
10-Q · filed 2026-05-15
$220.00K
derived: sum of 2 quarters · filed 2026-05-15
$266.00K
derived: sum of 3 quarters · filed 2026-05-15
$199.00K
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31-$83.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15
-$37.00K
derived: sum of 2 quarters · filed 2026-04-15
-$104.00K
derived: sum of 3 quarters · filed 2026-04-15
-$291.00K
10-K · filed 2026-04-15
2024-09-30$46.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19
-$21.00K
derived: sum of 2 quarters · filed 2025-11-19
-$208.00K
10-Q · filed 2025-11-19
-$76.00K
derived: sum of 4 quarters · filed 2025-11-19
2024-06-30-$67.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
-$254.00K
10-Q · filed 2025-08-08
-$122.00K
derived: sum of 3 quarters · filed 2025-08-08
-$95.00K
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31-$187.00K
10-Q · filed 2025-05-14
-$55.00K
derived: sum of 2 quarters · filed 2025-05-14
-$28.00K
derived: sum of 3 quarters · filed 2025-05-14
-$265.00K
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$132.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$159.00K
derived: sum of 2 quarters · filed 2025-03-31
-$78.00K
derived: sum of 3 quarters · filed 2025-03-31
-$1.90M
10-K · filed 2025-03-31
2023-09-30$27.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$210.00K
derived: sum of 2 quarters · filed 2024-11-12
-$2.04M
10-Q · filed 2024-11-12
-$6.54M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$237.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
-$2.06M
10-Q · filed 2024-08-06
-$6.57M
derived: sum of 3 quarters · filed 2024-08-06
-$9.78M
derived: sum of 4 quarters · filed 2024-08-06
2023-03-31-$1.83M
10-Q · filed 2024-05-14
-$6.33M
derived: sum of 2 quarters · filed 2024-05-14
-$9.54M
derived: sum of 3 quarters · filed 2024-05-14
-$5.12M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31-$4.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
-$7.72M
derived: sum of 2 quarters · filed 2024-03-29
-$3.30M
derived: sum of 3 quarters · filed 2024-03-29
-$2.08M
10-K · filed 2024-03-29
2022-09-30-$3.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$1.21M
derived: sum of 2 quarters · filed 2023-11-13
$2.43M
10-Q · filed 2023-11-13
$1.41M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$4.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
$5.64M
10-Q · filed 2023-08-04
$4.62M
derived: sum of 3 quarters · filed 2023-08-04
$7.62M
derived: sum of 4 quarters · filed 2023-08-04
2022-03-31$1.22M
10-Q · filed 2023-05-09
$202.00K
derived: sum of 2 quarters · filed 2023-05-09
$3.20M
derived: sum of 3 quarters · filed 2023-05-09
$3.22M
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31-$1.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03
$1.98M
derived: sum of 2 quarters · filed 2023-03-03
$1.99M
derived: sum of 3 quarters · filed 2023-03-03
$3.23M
10-K · filed 2023-03-03
2021-09-30$3.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$3.01M
derived: sum of 2 quarters · filed 2022-11-08
$4.25M
10-Q · filed 2022-11-08
$3.66M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30$13.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$1.25M
10-Q · filed 2022-08-11
$658.00K
derived: sum of 3 quarters · filed 2022-08-11
$1.30M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$1.24M
10-Q · filed 2022-05-16
$645.00K
derived: sum of 2 quarters · filed 2022-05-16
$1.29M
derived: sum of 3 quarters · filed 2022-05-16
$1.65M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31-$592.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
$49.00K
derived: sum of 2 quarters · filed 2022-03-29
$408.00K
derived: sum of 3 quarters · filed 2022-03-29
-$924.00K
10-K · filed 2022-03-29
2020-09-30$641.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$1.00M
derived: sum of 2 quarters · filed 2021-11-15
-$332.00K
10-Q · filed 2021-11-15
$182.00K
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$359.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
-$973.00K
10-Q · filed 2021-08-05
-$459.00K
derived: sum of 3 quarters · filed 2021-08-05
-$1.49M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31-$1.33M
10-Q · filed 2021-05-05
-$818.00K
derived: sum of 2 quarters · filed 2021-05-05
-$1.85M
derived: sum of 3 quarters · filed 2021-05-05
-$896.00K
derived: sum of 4 quarters · filed 2021-05-05
2019-12-31$514.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$521.00K
derived: sum of 2 quarters · filed 2021-02-25
$436.00K
derived: sum of 3 quarters · filed 2021-02-25
-$2.77M
10-K · filed 2021-02-25
2019-09-30-$1.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$78.00K
derived: sum of 2 quarters · filed 2020-11-05
-$3.28M
10-Q · filed 2020-11-05
$1.02M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30$957.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$2.25M
10-Q · filed 2020-08-06
$2.06M
derived: sum of 3 quarters · filed 2020-08-06
$754.00K
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31-$3.21M
10-Q · filed 2020-05-07
$1.10M
derived: sum of 2 quarters · filed 2020-05-07
-$203.00K
derived: sum of 3 quarters · filed 2020-05-07
$1.11M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31$4.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12
$3.00M
derived: sum of 2 quarters · filed 2020-02-12
$4.32M
derived: sum of 3 quarters · filed 2020-02-12
$4.09M
10-K · filed 2020-02-12
2018-09-30-$1.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$9.00K
derived: sum of 2 quarters · filed 2019-11-07
-$220.00K
10-Q · filed 2019-11-07
-$89.00K
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30$1.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
$1.08M
10-Q · filed 2019-08-06
$1.22M
derived: sum of 3 quarters · filed 2019-08-06
$1.10M
derived: sum of 4 quarters · filed 2019-08-06
2018-03-31-$229.00K
10-Q · filed 2019-05-09
-$98.00K
derived: sum of 2 quarters · filed 2019-05-09
-$216.00K
derived: sum of 3 quarters · filed 2019-05-09
-$1.22M
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31$131.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
$13.00K
derived: sum of 2 quarters · filed 2019-03-12
-$986.00K
derived: sum of 3 quarters · filed 2019-03-12
$205.00K
10-K · filed 2019-03-12
2017-09-30-$118.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
-$1.12M
derived: sum of 2 quarters · filed 2018-11-08
$74.00K
10-Q · filed 2018-11-08
$23.00K
derived: sum of 4 quarters · filed 2018-11-08
2017-06-30-$999.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$192.00K
10-Q · filed 2018-08-09
$141.00K
derived: sum of 3 quarters · filed 2018-08-09
-$1.10M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31$1.19M
10-Q · filed 2018-05-10
$1.14M
derived: sum of 2 quarters · filed 2018-05-10
-$103.00K
derived: sum of 3 quarters · filed 2018-05-10
2016-12-31-$51.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
-$1.29M
derived: sum of 2 quarters · filed 2018-04-02
-$343.00K
10-K · filed 2018-04-02
2016-09-30-$1.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
-$292.00K
10-Q · filed 2017-11-07
2016-06-30$951.00K
10-Q · filed 2017-08-31
2015-12-31$911.00K
10-K · filed 2018-04-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
MetaVia Inc. (MTVA)United States$0.011B-0.65
Moleculin Biotech, Inc. (MBRX)United States$0.011B
Theriva Biologics, Inc. (TOVX)United States$0.011B
Azitra, Inc. (AZTR)United States$0.010B-0.81
Dare Bioscience, Inc. (DARE)United States$0.011B
Medicus Pharma Ltd. (MDCX)$0.010B
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
Aprea Therapeutics, Inc. (APRE)United States$0.010B-0.78
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92